Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lobaplatin vs Cisplatin Adjuvant Chemotherapy in Esophageal Carcinoma
NCT03413436Phase 4Completed
- Sponsor
- Henan Cancer Hospital
- Start
- Jan 2018
- Primary completion
- Feb 2018
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of lobaplatin in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Henan Cancer Hospital. Started Jan 2018; status: completed.
02
Drugs
lobaplatin
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT03413436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03413436.